MXPA04001128A - Method for identifying substances which positively influence inflammatory conditions. - Google Patents
Method for identifying substances which positively influence inflammatory conditions.Info
- Publication number
- MXPA04001128A MXPA04001128A MXPA04001128A MXPA04001128A MXPA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A
- Authority
- MX
- Mexico
- Prior art keywords
- positively influence
- inflammatory conditions
- identifying substances
- influence inflammatory
- nhr
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to NHR-proteins involved in inflammatory processes and the modulation of the function of such a NHR-protein in order to positively influence inflammatory diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01119003 | 2001-08-06 | ||
PCT/EP2002/007937 WO2003014745A2 (en) | 2001-08-06 | 2002-07-17 | Method for identifying anti-inflammatory drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04001128A true MXPA04001128A (en) | 2004-05-20 |
Family
ID=8178260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04001128A MXPA04001128A (en) | 2001-08-06 | 2002-07-17 | Method for identifying substances which positively influence inflammatory conditions. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1425587A2 (en) |
JP (1) | JP2005503787A (en) |
AU (1) | AU2002321229A1 (en) |
CA (1) | CA2453913A1 (en) |
MX (1) | MXPA04001128A (en) |
WO (1) | WO2003014745A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005074969A2 (en) * | 2004-02-07 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1394899A (en) * | 1997-11-10 | 1999-05-31 | Research Foundation Of The State University Of New York, The | Opiate, cannabinoid, and estrogen receptors |
BR0009474A (en) * | 1999-03-11 | 2001-11-27 | Nuclear Receptor Res Ltd | Ligands for ppar nuclear receivers |
CA2284103A1 (en) * | 1999-09-30 | 2001-03-30 | Edith Bonnelye | Estrogen related receptor, err.alpha., a regulator of bone formation |
JP2004516038A (en) * | 2000-12-22 | 2004-06-03 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Methods for identifying substances that positively affect the inflammatory condition of chronic inflammatory airway disease |
AU2002237238A1 (en) * | 2000-12-22 | 2002-07-08 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Identification of modulators of dham-kinase and inflammatory diseases |
-
2002
- 2002-07-17 MX MXPA04001128A patent/MXPA04001128A/en not_active Application Discontinuation
- 2002-07-17 AU AU2002321229A patent/AU2002321229A1/en not_active Abandoned
- 2002-07-17 JP JP2003519426A patent/JP2005503787A/en not_active Abandoned
- 2002-07-17 CA CA002453913A patent/CA2453913A1/en not_active Abandoned
- 2002-07-17 WO PCT/EP2002/007937 patent/WO2003014745A2/en not_active Application Discontinuation
- 2002-07-17 EP EP02754896A patent/EP1425587A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003014745A2 (en) | 2003-02-20 |
AU2002321229A1 (en) | 2003-02-24 |
CA2453913A1 (en) | 2003-02-20 |
EP1425587A2 (en) | 2004-06-09 |
JP2005503787A (en) | 2005-02-10 |
WO2003014745A3 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60234464D1 (en) | Compositions and methods for selective nucleic acid isolation | |
DE69918089D1 (en) | BTK INHIBITORS AND METHOD FOR IDENTIFICATION AND USE | |
DE60131262D1 (en) | Ubiquitin-ligase-assay | |
ATE520466T1 (en) | APPARATUS AND METHOD FOR MODIFYING MAGNETICALLY IMMOBILIZED BIOMOLECULES | |
WO2002030353A3 (en) | NF-λB INHIBITORS | |
WO2002097130A3 (en) | Microstructures and use thereof for the directed evolution of biomolecules | |
PL1702066T3 (en) | Method and device for purifying nucleic acids | |
DE50113396D1 (en) | System for the targeted deformation of optical elements | |
AU2001269087A1 (en) | Method for selecting particles | |
ES2162277T3 (en) | SUBSTRATES AND INHIBITORS OF PROTEOLITIC ENZYMES. | |
WO2001075178A3 (en) | Methods for identifying peptide aptamers capable of altering a cell phenotype | |
EP1545453A4 (en) | Methods and reagents for treating infections of clostridium difficile and diseases associated therewith | |
DE60224275D1 (en) | MOLECULES AND METHOD FOR INHIBITING THE RELEASE OF KIM-1 | |
JO2242B1 (en) | Phosphatase inhibitors | |
FI20011353A (en) | Method and apparatus for clarifying and / or thickening the sludge | |
MXPA03007413A (en) | Composition and method for treating inflammatory disorders. | |
CA2418506A1 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
AU2002364914A8 (en) | Computer-implemented system and method for productivity enhancement | |
MXPA04001128A (en) | Method for identifying substances which positively influence inflammatory conditions. | |
WO2002061430A3 (en) | Methods and reagents for treating autoimmune disorders | |
NO20033921L (en) | Monoamine uptake inhibitor | |
MXPA03006828A (en) | System and method for cleaning and/or treating vehicle surfaces. | |
WO2002052269A3 (en) | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases | |
MXPA03005400A (en) | Method for the preparation of 11(12)-pentadecen-15-olides. | |
DE50201084D1 (en) | Process for the hydrogenation of unsaturated transition metal compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |